Target intelligence / Profile preview

Stomatin-like protein 1 (STOML1)

Target
STOML1
Molecular classification
Membrane protein, Stomatin family protein, Lipid transfer protein (contains sterol carrier protein-2 [SCP-2] domain), Ion channel modulator, Other (contains prohibitin/flotillin [SPFH] domain)
01

Overview

Stomatin-like protein 1 (STOML1) is a member of the stomatin protein family, predominantly expressed in brain, heart, and skeletal muscle, but detectable in other tissues as well[1][5]. It is a membrane-associated protein with a bipartite structure: an N-terminal stomatin domain and a C-terminal sterol carrier protein-2 (SCP-2) domain[1][2]. STOML1 primarily localizes to late endosomes, where it participates in cholesterol/sterol transfer and associates with detergent-resistant membranes (lipid rafts). It interacts directly with stomatin and plays a role in the formation of cholesterol-rich endosomal vesicles when cholesterol trafficking is impaired[1][2]. STOML1 can modulate acid-sensing ion channels (notably inhibits ASIC1 currents), and may play a regulatory role in neuronal signaling[3]. While implicated in lipid homeostasis and ion channel regulation, there are no known drugs directly targeting STOML1, and it is not currently considered a standard therapeutic target in clinical use.

Other names
SLP-1STORPhUNC-24UNC24MSTP019FLJ36370EPB72-like protein 1Protein unc-24 homologStomatin-related proteinslipin-1
02

Biological functions

Lipid/sterol transfer and transport (especially cholesterol to late endosomes)Modulation of acid-sensing ion channel (ASIC) activityProtein–protein interaction (notably with stomatin)Membrane organization
03

Disease associations

Neurodegenerative disease (role is suggested in related genes; STOML1 associated with Neuronitis and Overhydrated Hereditary Stomatocytosis, though specific pathogenesis remains unclear)

Beyond the preview

Go deeper on Stomatin-like protein 1 (STOML1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stomatin-like protein 1 (STOML1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call